Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate (Q39007706)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 March 2008

Language	Label	Description	Also known as
English	Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate	scientific article published on 18 March 2008

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate (English)

1 reference

Europe PubMed Central

8 September 2017

Trypanosoma cruzi

0 references

0 references

author name string

Germán H Fontanella

1

1 reference

Europe PubMed Central

8 September 2017

Kristof De Vusser

2

1 reference

Europe PubMed Central

8 September 2017

Wouter Laroy

3

1 reference

Europe PubMed Central

8 September 2017

Lucas Daurelio

4

1 reference

Europe PubMed Central

8 September 2017

Ana Lía Nocito

5

1 reference

Europe PubMed Central

8 September 2017

Silvia Revelli

6

1 reference

Europe PubMed Central

8 September 2017

Roland Contreras

7

1 reference

Europe PubMed Central

8 September 2017

language of work or name

0 references

publication date

18 March 2008

1 reference

Europe PubMed Central

8 September 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

8 September 2017

26

1 reference

Europe PubMed Central

8 September 2017

19

1 reference

Europe PubMed Central

8 September 2017

2322-2334

1 reference

Europe PubMed Central

8 September 2017

Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Structural and functional properties of Trypanosoma trans-sialidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective Immunity Against Trypanosoma cruzi Infection in a Highly Susceptible Mouse Strain After Vaccination with Genes Encoding the Amastigote Surface Protein-2 and Trans-Sialidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Control of Trypanosoma cruzi infection and changes in T-cell populations induced by a therapeutic DNA vaccine in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Preclinical and clinical safety studies on DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Carbohydrates in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Mannose receptor-mediated regulation of serum glycoprotein homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Use of HDEL-tagged Trichoderma reesei mannosyl oligosaccharide 1,2-alpha-D-mannosidase for N-glycan engineering in Pichia pastoris

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Heterologous protein expression in the methylotrophic yeast Pichia pastoris

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Production of human compatible high mannose-type (Man5GlcNAc2) sugar chains in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

In vivo synthesis of mammalian-like, hybrid-type N-glycans in Pichia pastoris

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Glycan-regulated antigen processing of a protein in the endoplasmic reticulum can uncover cryptic cytotoxic T cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Cloning of Trypanosoma cruzi trans-sialidase and expression in Pichia pastoris.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Ultrasensitive profiling and sequencing of N-linked oligosaccharides using standard DNA-sequencing equipment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

TNF-alpha is expressed at sites of parasite and tissue destruction in the spleen of mice acutely infected with Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

New technologies for making vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Trypanosome trans-sialidase targets TrkA tyrosine kinase receptor and induces receptor internalization and activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

A sexual dimorphism in intrathymic sialylation survey is revealed by the trans-sialidase from Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Acute Trypanosoma cruzi infection is associated with anemia, thrombocytopenia, leukopenia, and bone marrow hypoplasia: reversal by nifurtimox treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Innate and acquired immunity in the pathogenesis of Chagas disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Adjuvants designed for veterinary and human vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

The mannose receptor: linking homeostasis and immunity through sugar recognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Trypanosoma cruzi trans-sialidase potentiates T cell activation through antigen-presenting cells: role of IL-6 and Bruton's tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

Trans-sialidase: a unique enzyme activity discovered in the protozoan Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.060

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.02.060

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39007706&oldid=1801991959"